NCT03732677 2026-03-13
NIAGARA
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT04640623 2026-03-13
SunRISe-1
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT03474107 2026-01-09
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Astellas Pharma Inc
Phase 3 Completed